2019 ´ëÇÑÇ×±Õ¿ä¹ýÇÐȸ*´ëÇÑ°¨¿°ÇÐȸ Ãá°è Çмú´ëȸ : 2019-04-05±³À°ÀÏÀÚ : 2019-04-05
±³À°Àå¼Ò : ûÁÖ ±×·£µå ÇöóÀÚ È£ÅÚ
±³À°ÁÖÁ¦ :
2019 ´ëÇÑÇ×±Õ¿ä¹ýÇÐȸ*´ëÇÑ°¨¿°ÇÐȸ Ãá°è Çмú´ëȸÁÖÃÖ±â°ü : ´ëÇÑ°¨¿°ÇÐȸ
´ã´çÀÚ : ¹Ú½ÂÀ±
¿¬¶ôó : 02-557-1755
À̸ÞÀÏ :
ksc@ksac.or.kr ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 5Á¡ (ÀÏ¹Ý 4Á¡ / Çʼö 1Á¡)
Áö¿ª :
ÃæûºÏµµ±³À°½Ã°£ : 5 ½Ã°£ 10ºÐ
¼¼ºÎ¼ö°·á : 140,000¿ø
ºñ°í Àü°øÀÇ: Á¤È¸¿ø5¸¸ / ºñȸ¿ø7¸¸/ÇöÀå9¸¸ ÀüÀÓÀÇ: Á¤È¸¿ø 8¸¸/ºñȸ¿ø10¸¸/ÇöÀå12¸¸ Àü¹®ÀÇ+ÀÏ¹Ý : Á¤È¸¿ø10¸¸/ºñȸ¿ø 12¸¸/ ÇöÀå 14¸¸ *ÀϹÝ: Àǻ簡 ¾Æ´Ñ °æ¿ì(°£È£»ç, ¾à»çµî)
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04-05 Á÷ÁöȦ 07:30~08:00 Clinical cases: Protean clinical manifestation of extrapulmonary tuberculosis ¹Ú»ó¿ø(¼¿ïÀÇ´ë)
±³À°½Ã°£ 04-05 Á÷ÁöȦ 08:00~08:30 Recent update in antimicrobial susceptibility testing ÇãÈñÀç(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 04-05 ±×·£µåº¼·ë 08:30~09:30 Biktarvy: A powerful HIV treatment for today and the future Dr. Sorana Segal-Maurer(New York-Presbyterian Queens)
±³À°½Ã°£ 04-05 ±×·£µåº¼·ë 10:50~11:30 Plenary lecture I Clostridium difficile °¨¿°ÀÇ ±¹³» ÇöȲ ¹× Ư¡ ¹èÇöÁÖ(ÇѾçÀÇ´ë)
±³À°½Ã°£ 04-05 ±×·£µåº¼·ë 12:00~13:00 The efficacy and safety of DTG-based 2 drug regimens Áø¹ü½Ä(±¹¸³Áß¾ÓÀÇ·á¿ø)
±³À°½Ã°£ 04-05 ±×·£µåº¼·ë 15:00~15:30 Antimicrobial de-escalation, is it safe and ethical? ÃÖ¿ø¼®(°í·ÁÀÇ´ë)
±³À°½Ã°£ 04-05 ±×·£µåº¼·ë 15:30~16:00 Duration of antimicrobial therapy, how long is enough? ±è½Å¿ì(°æºÏÀÇ´ë)
±³À°½Ã°£ 04-05 ±×·£µåº¼·ë 16:00~16:30 CRP and procalcitonin in the management of bacterial infections ÃÖ»óÈ£(¿ï»êÀÇ´ë)